A Small Biotech With Two Complex Bispecific Antibody Candidates Benefits From A Blend Of Expertise And Flexibility
By Craig Parker, MBA, President & CEO, Surrozen
![iStock-1225143466-scientist-lab-research-development-test iStock-1225143466-scientist-lab-research-development-test](https://vertassets.blob.core.windows.net/image/81b607bd/81b607bd-7ca2-4bab-8910-4f4488d97116/375_250-istock_1225143466_scientist_lab_research_development_test.jpg)
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of ECM Connection? Subscribe today.
Subscribe to ECM Connection
X
Subscribe to ECM Connection
This website uses cookies to ensure you get the best experience on our website. Learn more